Hippo Holdings Inc(NYSE:HIPO)

Hippo Holdings Inc. provides personal property insurance brokerage services and underwrites insurance policies in the United States and the District of Columbia. Its insurance products include homeowners' insurance against risks of fire, wind, and theft; and commercial and personal lines of products...
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue: | |||||||||||||||||||
net earned premium | 98,900,000 | 99,100,000 | 99,700,000 | 94,000,000 | 87,300,000 | 77,000,000 | 70,600,000 | 64,400,000 | 60,500,000 | 38,500,000 | 32,900,000 | 22,300,000 | 13,800,000 | 11,600,000 | 10,700,000 | 11,200,000 | 9,000,000 | 9,000,000 | 10,900,000 |
commission income | 12,700,000 | 11,700,000 | 10,500,000 | 14,700,000 | 14,400,000 | 15,900,000 | 15,700,000 | 16,100,000 | 15,900,000 | 15,600,000 | 14,200,000 | 16,200,000 | 17,400,000 | 15,600,000 | 14,300,000 | 12,900,000 | 11,500,000 | 19,300,000 | 6,600,000 |
service and fee income | 3,200,000 | 3,000,000 | 3,100,000 | 2,900,000 | 2,800,000 | 2,800,000 | 3,000,000 | 3,000,000 | 2,800,000 | 3,800,000 | 4,900,000 | 3,800,000 | 3,200,000 | 3,600,000 | 3,200,000 | 3,500,000 | 3,600,000 | 3,700,000 | 3,700,000 |
net investment income | 6,700,000 | 6,600,000 | 7,300,000 | 5,700,000 | 5,800,000 | 6,200,000 | 6,200,000 | 6,100,000 | 5,900,000 | 6,600,000 | 5,700,000 | 5,400,000 | 5,400,000 | 5,000,000 | 2,500,000 | 1,100,000 | 400,000 | 100,000 | 100,000 |
total revenue | 121,500,000 | 120,400,000 | 120,600,000 | 117,300,000 | 110,300,000 | 101,900,000 | 95,500,000 | 89,600,000 | 85,100,000 | 64,500,000 | 57,700,000 | 47,700,000 | 39,800,000 | 35,800,000 | 30,700,000 | 28,700,000 | 24,500,000 | 32,100,000 | 21,300,000 |
yoy | 10.15% | 18.16% | 26.28% | 30.92% | 29.61% | 57.98% | 65.51% | 87.84% | 113.82% | 80.17% | 87.95% | 66.20% | 62.45% | 11.53% | 44.13% | ||||
qoq | 0.91% | -0.17% | 2.81% | 6.35% | 8.24% | 6.70% | 6.58% | 5.29% | 31.94% | 11.79% | 20.96% | 19.85% | 11.17% | 16.61% | 6.97% | 17.14% | -23.68% | 50.70% | |
expenses: | |||||||||||||||||||
losses and loss adjustment expenses | 47,500,000 | 45,500,000 | 47,500,000 | 44,500,000 | 92,400,000 | 44,400,000 | 51,600,000 | 60,400,000 | 52,600,000 | 30,800,000 | 36,500,000 | 76,700,000 | 37,700,000 | 25,800,000 | 23,900,000 | 29,200,000 | 22,500,000 | 19,400,000 | 26,300,000 |
insurance related expenses | 34,900,000 | 35,400,000 | 32,900,000 | 32,800,000 | 30,200,000 | 20,900,000 | 22,600,000 | 24,500,000 | 20,800,000 | 24,300,000 | 20,300,000 | 18,800,000 | 15,800,000 | 13,700,000 | 15,600,000 | 17,400,000 | 13,200,000 | 18,500,000 | 7,100,000 |
technology and development expenses | 9,400,000 | ||||||||||||||||||
sales and marketing expenses | 6,300,000 | ||||||||||||||||||
general and administrative expenses | 16,200,000 | ||||||||||||||||||
interest and other expense | 300,000 | 800,000 | 125,000 | 300,000 | -1,100,000 | -100,000 | -300,000 | -1,000,000 | 42,400,000 | -26,400,000 | |||||||||
total expenses | 114,300,000 | 113,600,000 | 22,500,000 | 113,300,000 | 155,900,000 | 54,800,000 | 100,700,000 | 126,100,000 | 118,000,000 | 103,500,000 | 108,300,000 | 152,700,000 | 107,600,000 | 95,800,000 | 157,900,000 | 100,400,000 | 90,800,000 | 91,100,000 | 51,100,000 |
income before income taxes | 7,200,000 | 6,800,000 | 98,100,000 | 4,000,000 | -45,600,000 | 47,100,000 | -5,200,000 | -36,500,000 | -32,900,000 | -39,000,000 | -50,600,000 | -105,000,000 | -67,800,000 | -60,000,000 | -127,200,000 | -71,700,000 | -66,300,000 | -59,000,000 | -29,800,000 |
income tax expense | 100,000 | 800,000 | 100,000 | -200,000 | 250,000 | 700,000 | 200,000 | 50,000 | -300,000 | 200,000 | 300,000 | 200,000 | 300,000 | 300,000 | 200,000 | ||||
net income | 7,100,000 | 6,000,000 | 98,100,000 | 3,900,000 | -45,400,000 | 46,900,000 | -5,200,000 | -37,200,000 | -33,100,000 | -39,300,000 | -50,300,000 | -105,200,000 | -68,100,000 | -60,500,000 | -127,500,000 | -72,000,000 | -66,500,000 | -59,300,000 | -29,900,000 |
yoy | -115.64% | -87.21% | -1986.54% | -110.48% | 37.16% | -219.34% | -89.66% | -64.64% | -51.40% | -35.04% | -60.55% | 46.11% | 2.41% | 2.02% | 326.42% | ||||
qoq | 18.33% | -93.88% | 2415.38% | -108.59% | -196.80% | -1001.92% | -86.02% | 12.39% | -15.78% | -21.87% | -52.19% | 54.48% | 12.56% | -52.55% | 77.08% | 8.27% | 12.14% | 98.33% | |
net income margin % | 5.84% | 4.98% | 81.34% | 3.32% | -41.16% | 46.03% | -5.45% | -41.52% | -38.90% | -60.93% | -87.18% | -220.55% | -171.11% | -168.99% | -415.31% | -250.87% | -271.43% | -184.74% | -140.38% |
net income attributable to noncontrolling interests, net of tax | 2,600,000 | 2,300,000 | 2,700,000 | 3,300,000 | 3,300,000 | 2,600,000 | 3,000,000 | 2,800,000 | 2,600,000 | 1,700,000 | 2,600,000 | 1,700,000 | 1,500,000 | 1,100,000 | 1,400,000 | 1,000,000 | |||
net income attributable to hippo | 7,100,000 | 6,000,000 | 98,100,000 | 1,300,000 | |||||||||||||||
other comprehensive income: | |||||||||||||||||||
change in net unrealized gain on investments, net of tax | -2,400,000 | 400,000 | 1,300,000 | 700,000 | 2,100,000 | -3,200,000 | 4,100,000 | -200,000 | -500,000 | ||||||||||
comprehensive income attributable to hippo | 4,700,000 | 6,400,000 | 99,400,000 | 2,000,000 | |||||||||||||||
per share data: | |||||||||||||||||||
net income per share | -1.91 | 1.8 | -0.34 | -1.64 | -1.47 | -1.73 | -2.24 | -4.61 | -3.01 | -2.73 | -5.66 | -0.13 | -0.12 | 0.41 | -0.08 | ||||
basic | 0.27 | 0.24 | 3.9 | 0.05 | |||||||||||||||
diluted | 0.27 | 0.25 | 3.77 | 0.05 | |||||||||||||||
weighted-average common shares outstanding | |||||||||||||||||||
basic | 25,840,004 | 25,253,520 | 25,183,389 | 25,343,457 | |||||||||||||||
diluted | 26,354,271 | 26,011,391 | 26,025,069 | 26,023,780 | |||||||||||||||
technology and development | 6,050,000 | 8,000,000 | 8,100,000 | 8,100,000 | 7,600,000 | 7,000,000 | 7,800,000 | 8,300,000 | 10,400,000 | 11,900,000 | 13,100,000 | 11,600,000 | 11,500,000 | 14,800,000 | 16,500,000 | 14,700,000 | 13,500,000 | 8,300,000 | |
sales and marketing | 6,525,000 | 8,000,000 | 9,200,000 | 8,900,000 | 10,900,000 | 12,500,000 | 13,400,000 | 14,400,000 | 16,200,000 | 18,900,000 | 22,600,000 | 22,400,000 | 28,100,000 | 29,400,000 | 19,400,000 | 24,900,000 | 25,700,000 | 22,400,000 | |
general and administrative | 12,600,000 | 16,500,000 | 17,400,000 | 16,500,000 | 17,200,000 | 15,300,000 | 19,900,000 | 18,300,000 | 17,600,000 | 20,700,000 | 21,500,000 | 19,800,000 | 17,800,000 | 19,000,000 | 18,200,000 | 16,500,000 | 18,600,000 | 13,400,000 | |
impairment and restructuring charges | 3,800,000 | 1,200,000 | 3,600,000 | 55,300,000 | |||||||||||||||
gain on sale of business | -95,000,000 | -46,200,000 | -8,200,000 | ||||||||||||||||
net income attributable to hippo - basic and diluted | 12.925 | 98.1 | 1.3 | ||||||||||||||||
weighted-average shares used for eps calculation | 24,978,901 | 24,699,913 | 25,068,472 | 24,633,960 | 24,225,650 | 23,578,922 | 23,729,570 | 23,387,767 | 23,198,491 | 22,747,101 | 22,839,916 | 566,107,642 | 561,620,061 | 272,168,933 | 386,882,408 | ||||
basic | 25,840,004 | 25,253,520 | 25,183,389 | 25,343,457 | |||||||||||||||
diluted | 26,354,271 | 26,011,391 | 26,025,069 | 26,023,780 | |||||||||||||||
other expense | 100,000 | -200,000 | -25,000 | -100,000 | 100,000 | ||||||||||||||
net loss attributable to hippo | -47,700,000 | 44,200,000 | -8,500,000 | -40,500,000 | -35,700,000 | -42,300,000 | -53,100,000 | -107,800,000 | -69,800,000 | -63,100,000 | -129,200,000 | -73,500,000 | -67,600,000 | -60,700,000 | -30,900,000 | ||||
comprehensive loss attributable to hippo | -45,600,000 | 41,000,000 | -4,400,000 | -40,700,000 | -36,200,000 | -38,100,000 | -53,800,000 | -108,900,000 | -68,100,000 | -62,300,000 | -132,100,000 | -75,100,000 | -70,200,000 | -61,100,000 | -31,000,000 | ||||
net loss attributable to hippo - basic and diluted | -47.7 | -21.175 | -8.5 | -40.5 | -35.7 | -57.7 | -53.1 | -107.8 | -69.8 | -67.575 | -129.2 | -73.5 | -67.6 | -77.675 | -30.9 | ||||
weighted-average shares used for eps calculation | 24,978,901 | 24,699,913 | 25,068,472 | 24,633,960 | 24,225,650 | 23,578,922 | 23,729,570 | 23,387,767 | 23,198,491 | 22,747,101 | 22,839,916 | 566,107,642 | 561,620,061 | 272,168,933 | 386,882,408 | ||||
net income per share | -1.91 | 1.8 | -0.34 | -1.64 | -1.47 | -1.73 | -2.24 | -4.61 | -3.01 | -2.73 | -5.66 | -0.13 | -0.12 | 0.41 | -0.08 | ||||
change in net unrealized gain or loss on investments, net of tax | -25,000 | -700,000 | -1,100,000 | 1,700,000 | 800,000 | -2,900,000 | -1,600,000 | -2,600,000 | -400,000 | -100,000 | |||||||||
income taxes expense | 300,000 | 100,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||
investments: | |||||||||||||||||||||
fixed maturities available-for-sale, at fair value | 298,700,000 | 293,400,000 | 245,500,000 | 237,300,000 | 212,200,000 | 205,700,000 | 201,800,000 | 167,000,000 | 162,700,000 | 161,700,000 | 141,500,000 | 135,600,000 | 141,000,000 | 121,100,000 | 109,200,000 | 102,600,000 | 86,500,000 | 54,900,000 | 59,700,000 | ||
short-term investments, at fair value | 125,200,000 | 152,500,000 | 174,700,000 | 167,800,000 | 175,400,000 | 167,600,000 | 152,500,000 | 148,500,000 | 124,700,000 | 188,500,000 | 228,800,000 | 290,400,000 | |||||||||
total investments | 423,900,000 | 445,900,000 | 420,200,000 | 405,100,000 | 387,600,000 | 373,300,000 | 354,300,000 | 315,500,000 | 287,400,000 | 348,800,000 | 330,000,000 | 364,400,000 | 431,400,000 | 445,900,000 | 330,800,000 | 454,300,000 | 435,400,000 | 64,000,000 | 72,000,000 | ||
cash and cash equivalents | 275,400,000 | 218,300,000 | 247,700,000 | 198,900,000 | 140,900,000 | 197,600,000 | 191,200,000 | 175,900,000 | 223,400,000 | 142,100,000 | 228,400,000 | 200,200,000 | 188,900,000 | 194,500,000 | 346,500,000 | 277,500,000 | 336,800,000 | 775,600,000 | 778,700,000 | ||
restricted cash | 29,400,000 | 31,800,000 | 24,500,000 | 26,900,000 | 39,300,000 | 35,200,000 | 39,700,000 | 44,300,000 | 39,900,000 | 53,000,000 | 41,000,000 | 38,200,000 | 31,800,000 | 50,000,000 | 46,400,000 | 47,000,000 | 44,800,000 | 43,100,000 | 44,100,000 | ||
accounts receivable | 282,100,000 | 250,100,000 | 236,700,000 | 227,100,000 | 172,800,000 | 167,000,000 | 157,800,000 | 167,400,000 | 153,800,000 | 145,200,000 | 145,400,000 | 148,200,000 | 133,600,000 | 107,200,000 | 89,800,000 | 66,600,000 | 61,000,000 | 56,500,000 | 60,300,000 | ||
reinsurance recoverable on paid and unpaid losses and lae | 398,100,000 | 321,300,000 | 302,600,000 | 326,000,000 | 285,300,000 | 279,800,000 | 290,800,000 | 290,100,000 | 281,300,000 | 297,300,000 | 332,700,000 | 300,600,000 | 286,300,000 | 337,300,000 | 291,400,000 | 321,400,000 | 266,900,000 | 279,400,000 | |||
prepaid reinsurance premiums | 386,700,000 | 353,700,000 | 336,600,000 | 296,400,000 | 249,300,000 | 274,200,000 | 292,300,000 | 291,300,000 | 275,300,000 | 335,600,000 | 375,500,000 | 375,200,000 | 326,800,000 | 309,900,000 | 301,600,000 | 263,400,000 | 236,000,000 | 231,600,000 | 228,100,000 | ||
ceding commissions receivable | 132,800,000 | 98,700,000 | 123,100,000 | 107,700,000 | 85,700,000 | 79,500,000 | 89,000,000 | 81,700,000 | 82,200,000 | 73,800,000 | 79,900,000 | 70,100,000 | 59,900,000 | 45,800,000 | 56,300,000 | 50,000,000 | 49,200,000 | 41,600,000 | 38,000,000 | ||
capitalized internal use software | 42,300,000 | 43,000,000 | 43,300,000 | 47,200,000 | 47,400,000 | 48,100,000 | 50,200,000 | 49,900,000 | 48,900,000 | 48,400,000 | 46,900,000 | 44,000,000 | 41,200,000 | 38,800,000 | 36,800,000 | 34,000,000 | 30,300,000 | 25,900,000 | 21,600,000 | ||
intangible assets | 13,600,000 | 13,800,000 | 14,000,000 | 14,300,000 | 16,100,000 | 17,000,000 | 23,800,000 | 25,000,000 | 26,200,000 | 27,300,000 | 23,600,000 | 24,700,000 | 25,800,000 | 26,900,000 | 28,000,000 | 29,200,000 | 30,300,000 | 32,200,000 | 33,700,000 | ||
other assets | 77,600,000 | 103,600,000 | 106,200,000 | 75,300,000 | 75,300,000 | 66,200,000 | 67,300,000 | 68,500,000 | 69,100,000 | 69,200,000 | 79,000,000 | 83,100,000 | 64,700,000 | 63,600,000 | 56,500,000 | 62,500,000 | 75,800,000 | 51,800,000 | 49,100,000 | ||
total assets | 2,061,900,000 | 1,905,500,000 | 1,873,600,000 | 1,706,200,000 | 1,540,400,000 | 1,543,400,000 | 1,545,400,000 | 1,510,300,000 | 1,496,300,000 | 1,524,700,000 | 1,647,000,000 | 1,680,800,000 | 1,604,700,000 | 1,568,900,000 | 1,630,000,000 | 1,629,400,000 | 1,674,500,000 | 1,642,700,000 | 1,658,200,000 | 230,905,463 | 231,219,945 |
liabilities and stockholders’ equity | |||||||||||||||||||||
liabilities: | |||||||||||||||||||||
loss and loss adjustment expense reserve | 482,600,000 | 384,400,000 | 389,000,000 | 400,800,000 | 350,000,000 | 351,100,000 | 346,900,000 | 336,600,000 | 322,500,000 | 359,900,000 | 367,600,000 | 305,200,000 | 293,800,000 | 321,500,000 | 268,800,000 | 282,400,000 | 260,800,000 | 239,700,000 | |||
unearned premiums | 615,300,000 | 579,700,000 | 564,400,000 | 506,200,000 | 446,000,000 | 457,900,000 | 473,800,000 | 452,700,000 | 407,300,000 | 419,200,000 | 441,800,000 | 423,100,000 | 365,700,000 | 341,300,000 | 316,500,000 | 282,900,000 | 252,100,000 | 253,100,000 | 244,300,000 | ||
reinsurance premiums payable | 356,300,000 | 304,400,000 | 332,100,000 | 302,900,000 | 238,300,000 | 248,600,000 | 261,200,000 | 246,600,000 | 263,200,000 | 260,100,000 | 291,100,000 | 302,700,000 | 249,500,000 | 207,100,000 | 215,900,000 | 192,400,000 | 201,700,000 | 159,400,000 | 162,100,000 | ||
provision for commission | 39,300,000 | 36,300,000 | 38,000,000 | 38,400,000 | 38,700,000 | 34,300,000 | 31,100,000 | 31,300,000 | 29,000,000 | 24,700,000 | 18,000,000 | 12,700,000 | 8,700,000 | 5,000,000 | 13,400,000 | 13,300,000 | 14,400,000 | 12,300,000 | 11,200,000 | ||
surplus note | 47,900,000 | 47,900,000 | 47,900,000 | 47,900,000 | |||||||||||||||||
accrued expenses and other liabilities | 71,800,000 | 80,700,000 | 85,300,000 | 77,200,000 | 90,900,000 | 87,400,000 | 98,100,000 | 106,200,000 | 105,400,000 | 113,500,000 | 124,900,000 | 127,700,000 | 132,600,000 | 128,200,000 | 123,700,000 | 120,600,000 | 101,100,000 | 83,800,000 | 61,900,000 | ||
total liabilities | 1,613,200,000 | 1,469,400,000 | 1,452,100,000 | 1,372,100,000 | 1,214,700,000 | 1,178,200,000 | 1,215,300,000 | 1,183,700,000 | 1,141,500,000 | 1,140,000,000 | 1,235,700,000 | 1,233,800,000 | 1,061,700,000 | 975,400,000 | 991,000,000 | 878,000,000 | 865,800,000 | 781,000,000 | 754,500,000 | 26,151,898 | 23,834,287 |
commitments and contingencies | |||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||
common stock, 0.0001 par value per share... | |||||||||||||||||||||
additional paid-in capital | 1,659,400,000 | 1,651,500,000 | 1,643,300,000 | 1,653,700,000 | 1,646,000,000 | 1,639,700,000 | 1,645,100,000 | 1,636,800,000 | 1,624,700,000 | 1,615,200,000 | 1,606,100,000 | 1,590,900,000 | 1,574,700,000 | 1,558,000,000 | 1,540,800,000 | 1,522,800,000 | 1,504,400,000 | 1,488,300,000 | 1,469,100,000 | 11,565,268 | 8,933,205 |
accumulated other comprehensive income | -600,000 | 1,800,000 | 1,400,000 | 100,000 | -700,000 | -400,000 | |||||||||||||||
accumulated deficit | -1,210,100,000 | -1,217,200,000 | -1,223,200,000 | -1,321,300,000 | -1,322,600,000 | -1,274,900,000 | -1,319,200,000 | -1,310,600,000 | -1,270,100,000 | -1,234,400,000 | -1,192,000,000 | -1,138,900,000 | -1,031,100,000 | -961,100,000 | -898,000,000 | -768,800,000 | -695,600,000 | -628,000,000 | -567,300,000 | -6,566,141 | -3,934,048 |
total stockholders’ equity | 448,700,000 | 436,100,000 | 421,500,000 | 334,100,000 | 325,700,000 | 365,200,000 | 330,100,000 | 326,600,000 | 354,800,000 | 384,700,000 | 411,300,000 | 447,000,000 | 543,000,000 | 593,500,000 | 639,000,000 | 751,400,000 | 808,700,000 | 861,700,000 | 903,700,000 | ||
total liabilities and stockholders’ equity | 2,061,900,000 | 1,905,500,000 | 1,873,600,000 | 1,706,200,000 | 1,540,400,000 | 1,543,400,000 | 1,545,400,000 | 1,510,300,000 | 1,496,300,000 | 1,524,700,000 | 1,647,000,000 | 1,680,800,000 | 1,604,700,000 | 1,568,900,000 | 1,630,000,000 | 1,629,400,000 | 1,674,500,000 | ||||
reinsurance recoverable on paid and unpaid losses and loss adjustment expenses | 346,600,000 | ||||||||||||||||||||
losses and loss adjustment expense reserve | 420,400,000 | ||||||||||||||||||||
common stock, 0.0001 par value... | |||||||||||||||||||||
total hippo stockholders’ equity | 436,100,000 | 421,500,000 | 332,500,000 | 322,800,000 | 326,400,000 | 322,600,000 | 351,200,000 | 407,000,000 | 445,600,000 | 538,300,000 | 635,000,000 | 749,100,000 | 805,500,000 | ||||||||
noncontrolling interest | 1,600,000 | 2,900,000 | 3,100,000 | 3,700,000 | 4,000,000 | 3,600,000 | 6,800,000 | 4,300,000 | 1,400,000 | 4,700,000 | 3,600,000 | 4,000,000 | 2,300,000 | 3,200,000 | 2,100,000 | 2,300,000 | |||||
assets held for sale | 4,700,000 | ||||||||||||||||||||
liabilities held for sale | 10,500,000 | ||||||||||||||||||||
accumulated other comprehensive loss | -600,000 | -2,700,000 | 500,000 | -3,600,000 | -3,400,000 | -2,900,000 | -7,100,000 | -6,400,000 | -5,300,000 | -7,000,000 | -7,800,000 | -4,900,000 | -3,300,000 | ||||||||
stockholders’ equity | |||||||||||||||||||||
total hippo stockholders' equity | 362,100,000 | 377,900,000 | 589,900,000 | 859,600,000 | 901,400,000 | ||||||||||||||||
short-term investments | 187,100,000 | 324,800,000 | 221,600,000 | 351,700,000 | 348,900,000 | 9,100,000 | 12,300,000 | ||||||||||||||
goodwill | 53,500,000 | 53,500,000 | 53,500,000 | 53,200,000 | |||||||||||||||||
contingent consideration liability | 14,100,000 | 11,600,000 | 11,500,000 | ||||||||||||||||||
liabilities, convertible preferred stock, and stockholders’ equity | |||||||||||||||||||||
convertible promissory notes | |||||||||||||||||||||
derivative liability on notes | |||||||||||||||||||||
preferred stock warrant liabilities | |||||||||||||||||||||
convertible preferred stock: | |||||||||||||||||||||
preferred stock, 0.0001 par value per share... | |||||||||||||||||||||
total liabilities, convertible preferred stock, and stockholders’ equity | 1,642,700,000 | 1,658,200,000 | |||||||||||||||||||
fiduciary liabilities | 23,800,000 | ||||||||||||||||||||
assets: | |||||||||||||||||||||
current assets: | |||||||||||||||||||||
cash | 101,045 | 214,015 | |||||||||||||||||||
prepaid expenses | 800,310 | 934,320 | |||||||||||||||||||
total current assets | 901,355 | 1,148,335 | |||||||||||||||||||
cash and investments held in trust account | 230,004,108 | 230,071,610 | |||||||||||||||||||
liabilities and shareholders’ equity: | |||||||||||||||||||||
current liabilities: | |||||||||||||||||||||
accounts payable | 89,189 | 22,500 | |||||||||||||||||||
accrued expenses | 874,866 | 866,866 | |||||||||||||||||||
due to related party | 334,663 | 168,661 | |||||||||||||||||||
total current liabilities | 1,298,718 | 1,058,027 | |||||||||||||||||||
deferred legal fees | 200,000 | 200,000 | |||||||||||||||||||
deferred underwriting commissions | 8,050,000 | 8,050,000 | |||||||||||||||||||
derivative warrant liabilities | 16,603,180 | 14,526,260 | |||||||||||||||||||
class a ordinary shares; 19,975,356 and 20,484,749 shares subject to possible redemption at 10.00 per share at june 30, 2021 and december 31, 2020, respectively | 199,753,560 | ||||||||||||||||||||
shareholders’ equity: | |||||||||||||||||||||
preference shares, 0.0001 par value... | |||||||||||||||||||||
class a ordinary shares, 0.0001 par value... | 303 | 276 | |||||||||||||||||||
redemption) at june 30, 2021 and december 31, 2020, respectively | |||||||||||||||||||||
class b ordinary shares, 0.0001 par value... | 575 | 575 | |||||||||||||||||||
total shareholders’ equity | 5,000,005 | 5,000,008 | |||||||||||||||||||
total liabilities and shareholders’ equity | 230,905,463 | 231,219,945 | |||||||||||||||||||
class a ordinary shares; 20,238,565 and 20,484,749 shares subject to possible redemption at 10.00 per share at march 31, 2021 and december 31, 2020, respectively | 202,385,650 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||
net cash from operating activities | 8,500,000 | 3,200,000 | 16,900,000 | 24,700,000 | -35,600,000 | -6,400,000 | 46,800,000 | -10,600,000 | 17,700,000 | -48,500,000 | 1,100,000 | -9,300,000 | -35,700,000 | -30,100,000 | -43,000,000 | -29,800,000 | -58,600,000 | 2,600,000 |
capital expenditures | -3,200,000 | -3,500,000 | -3,400,000 | -3,500,000 | -2,900,000 | -1,400,000 | -3,400,000 | -3,800,000 | -3,400,000 | -4,500,000 | -4,700,000 | -4,600,000 | -3,500,000 | -5,500,000 | -4,500,000 | -6,200,000 | -12,600,000 | |
free cash flows | 5,300,000 | -300,000 | 13,500,000 | 21,200,000 | -38,500,000 | -7,800,000 | 43,400,000 | -14,400,000 | 14,300,000 | -53,000,000 | -3,600,000 | -13,900,000 | -33,600,000 | -48,500,000 | -34,300,000 | -64,800,000 | -10,000,000 | |
cash flows from investing activities: | ||||||||||||||||||
capitalized internal use software costs | -3,100,000 | -3,500,000 | -3,400,000 | -3,500,000 | -2,800,000 | -1,300,000 | -3,400,000 | -3,700,000 | -3,300,000 | -4,100,000 | -4,500,000 | -4,600,000 | -3,900,000 | -3,400,000 | -3,700,000 | -3,900,000 | -3,800,000 | -11,900,000 |
purchases of property and equipment | -100,000 | 0 | -100,000 | -100,000 | 0 | -100,000 | -100,000 | -400,000 | -200,000 | -100,000 | -1,800,000 | -600,000 | -2,400,000 | -700,000 | ||||
purchases of fixed maturities | -29,400,000 | -65,800,000 | -23,200,000 | -33,700,000 | -15,700,000 | -27,000,000 | -46,700,000 | -6,700,000 | -17,300,000 | |||||||||
maturities of fixed maturities | 20,900,000 | 20,100,000 | 11,100,000 | 9,200,000 | 11,200,000 | 19,900,000 | 11,000,000 | 3,800,000 | 14,400,000 | |||||||||
sales of fixed maturities | 1,100,000 | 1,700,000 | 0 | 0 | 800,000 | 600,000 | ||||||||||||
purchases of short-term investments | -65,300,000 | -60,600,000 | -78,300,000 | -98,300,000 | -50,400,000 | -97,100,000 | -58,200,000 | -77,200,000 | -37,600,000 | |||||||||
maturities of short-term investments | 91,400,000 | 79,100,000 | 73,700,000 | 99,800,000 | 46,800,000 | 79,600,000 | 50,000,000 | 54,800,000 | 101,800,000 | |||||||||
sales of short-term investments | 2,000,000 | 3,300,000 | 600,000 | 0 | 0 | |||||||||||||
proceeds from deferred consideration | 25,000,000 | |||||||||||||||||
net cash from investing activities | 42,500,000 | -25,700,000 | 47,400,000 | -21,900,000 | -11,000,000 | 27,800,000 | -27,900,000 | -28,100,000 | 58,500,000 | -22,000,000 | 30,800,000 | 35,000,000 | 13,800,000 | -115,200,000 | 112,500,000 | -25,000,000 | -378,200,000 | -7,100,000 |
cash flows from financing activities: | ||||||||||||||||||
taxes paid related to net share settlement of equity awards | 0 | -4,000,000 | -2,100,000 | -3,300,000 | -3,600,000 | -2,500,000 | -2,700,000 | -1,100,000 | -700,000 | -1,100,000 | -2,000,000 | -900,000 | -400,000 | -800,000 | -1,700,000 | -1,000,000 | ||
proceeds from issuance of common stock | 1,000,000 | 1,000,000 | 500,000 | 1,300,000 | 1,000,000 | 3,700,000 | 800,000 | 1,200,000 | 1,000,000 | |||||||||
payments of contingent consideration | 0 | 0 | -200,000 | -200,000 | -200,000 | -200,000 | -200,000 | -300,000 | -300,000 | -300,000 | -300,000 | -400,000 | -600,000 | |||||
distributions to noncontrolling interests | 0 | |||||||||||||||||
other | 2,700,000 | 0 | -2,300,000 | 0 | 100,000 | -1,000,000 | 0 | 0 | 0 | -2,000,000 | -8,900,000 | |||||||
net cash from financing activities | 3,700,000 | 400,000 | -17,900,000 | 42,800,000 | -6,000,000 | -19,500,000 | -8,200,000 | -4,400,000 | -8,000,000 | -3,800,000 | -900,000 | -8,000,000 | -1,900,000 | -3,100,000 | -1,100,000 | -2,300,000 | -300,000 | 400,000 |
net increase in cash, cash equivalents, and restricted cash | 54,700,000 | -22,100,000 | 46,400,000 | 45,600,000 | -52,600,000 | 1,900,000 | 10,700,000 | -43,100,000 | 68,200,000 | -23,800,000 | -148,400,000 | 68,400,000 | -57,100,000 | -437,100,000 | -4,100,000 | |||
cash, cash equivalents, and restricted cash at the beginning of the period | 250,100,000 | 0 | 0 | 0 | 232,800,000 | 0 | 0 | 0 | 195,100,000 | 0 | 0 | 0 | 244,500,000 | 0 | 0 | 0 | 818,700,000 | 0 |
cash, cash equivalents, and restricted cash at the end of the period | 304,800,000 | -22,100,000 | 46,400,000 | 45,600,000 | 180,200,000 | 1,900,000 | 10,700,000 | -43,100,000 | 263,300,000 | -74,300,000 | 31,000,000 | 17,700,000 | 220,700,000 | -148,400,000 | 68,400,000 | -57,100,000 | 381,600,000 | -4,100,000 |
net income | ||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||
depreciation and amortization | 5,800,000 | 5,900,000 | 5,900,000 | 5,600,000 | 5,400,000 | 4,900,000 | 5,200,000 | 4,300,000 | 4,000,000 | 3,800,000 | 3,500,000 | 3,900,000 | 3,300,000 | |||||
stock–based compensation expense | 8,900,000 | 9,000,000 | 11,900,000 | 8,400,000 | 10,800,000 | 13,900,000 | 16,700,000 | 16,100,000 | 15,600,000 | 17,000,000 | 15,900,000 | 13,400,000 | ||||||
fair value adjustments | -500,000 | 300,000 | 400,000 | 1,500,000 | ||||||||||||||
impairment and restructuring charges | 0 | 0 | ||||||||||||||||
gain on sale of business | -46,200,000 | |||||||||||||||||
other non-cash items | 400,000 | -2,000,000 | -2,200,000 | -2,400,000 | -500,000 | -2,100,000 | -3,000,000 | -1,800,000 | -2,700,000 | -500,000 | 0 | 200,000 | ||||||
changes in assets and liabilities | ||||||||||||||||||
accounts receivable | -9,300,000 | 9,600,000 | -13,500,000 | -8,700,000 | 200,000 | 2,800,000 | -14,600,000 | -26,400,000 | -17,600,000 | -23,200,000 | -5,600,000 | -4,500,000 | 2,900,000 | |||||
reinsurance recoverables | ||||||||||||||||||
ceding commissions receivable | 9,600,000 | -7,400,000 | 500,000 | -8,400,000 | 6,200,000 | -9,900,000 | -10,200,000 | -14,100,000 | 10,500,000 | -6,300,000 | -800,000 | -7,600,000 | -3,600,000 | |||||
prepaid reinsurance premiums | 18,100,000 | -1,000,000 | -16,000,000 | 60,300,000 | 40,000,000 | -300,000 | -48,500,000 | -16,900,000 | -8,300,000 | -38,200,000 | -27,400,000 | -4,400,000 | -3,500,000 | |||||
other assets | -200,000 | -100,000 | -2,800,000 | -3,300,000 | 6,100,000 | 2,800,000 | -600,000 | -2,100,000 | -6,400,000 | 6,200,000 | 12,400,000 | -3,300,000 | -200,000 | |||||
provision for commission | 3,300,000 | -200,000 | 2,300,000 | 4,300,000 | 6,700,000 | 5,300,000 | 4,000,000 | 3,700,000 | -8,400,000 | 100,000 | -1,100,000 | 2,100,000 | 1,000,000 | |||||
accrued expenses and other liabilities | -8,100,000 | -4,900,000 | 1,600,000 | -6,100,000 | -12,100,000 | -1,700,000 | 3,300,000 | 5,000,000 | 4,100,000 | 8,200,000 | 9,600,000 | -2,300,000 | 16,400,000 | |||||
losses and loss adjustment expense reserves | ||||||||||||||||||
unearned premiums | -15,900,000 | 21,100,000 | 45,500,000 | -12,000,000 | -22,700,000 | 18,800,000 | 57,400,000 | 24,400,000 | 24,800,000 | 33,600,000 | 30,800,000 | -1,000,000 | 8,800,000 | |||||
reinsurance premiums payable | -12,600,000 | 14,700,000 | -16,600,000 | 3,000,000 | -31,000,000 | -11,700,000 | 53,300,000 | 42,400,000 | -8,800,000 | 23,500,000 | -9,300,000 | 42,300,000 | -2,800,000 | |||||
proceeds from sale of business | ||||||||||||||||||
proceeds from surplus note | 0 | 0 | ||||||||||||||||
share repurchases under program | 0 | 0 | 0 | -1,600,000 | -200,000 | |||||||||||||
acquisitions of noncontrolling interests | 0 | |||||||||||||||||
distributions to noncontrolling interests and other | -600,000 | 100,000 | -4,100,000 | -3,500,000 | -3,800,000 | -6,100,000 | -2,700,000 | -7,600,000 | ||||||||||
proceeds from sale of business, net of cash disposed | 48,000,000 | |||||||||||||||||
net loss | 46,900,000 | -5,200,000 | -37,200,000 | -33,100,000 | -39,300,000 | -50,300,000 | -105,300,000 | -68,100,000 | -60,500,000 | -127,500,000 | -72,000,000 | -66,500,000 | -59,300,000 | |||||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||||
changes in assets and liabilities: | ||||||||||||||||||
reinsurance recoverable on paid and unpaid losses and lae | -5,500,000 | 11,000,000 | -700,000 | -8,800,000 | 16,000,000 | 35,700,000 | -32,100,000 | -14,600,000 | 51,000,000 | -45,900,000 | 30,000,000 | -54,500,000 | 12,500,000 | |||||
loss and loss adjustment expense reserves | -1,100,000 | 4,200,000 | 10,300,000 | 14,100,000 | -37,400,000 | -7,700,000 | 62,400,000 | 11,400,000 | -27,700,000 | 52,700,000 | -13,600,000 | 21,600,000 | 21,100,000 | |||||
assets disposed from sale of business | ||||||||||||||||||
impairment charges | 3,300,000 | 0 | ||||||||||||||||
other changes in fair value | ||||||||||||||||||
change in fair value of contingent consideration liability | 1,500,000 | 800,000 | 2,900,000 | 800,000 | 1,500,000 | 200,000 | -800,000 | 3,200,000 | 1,400,000 | |||||||||
net decrease in cash, cash equivalents, and restricted cash | ||||||||||||||||||
change in fair value of warrant liability | 200,000 | -1,200,000 | -200,000 | -1,400,000 | -1,200,000 | -4,700,000 | ||||||||||||
purchases of investments | -83,500,000 | -96,000,000 | -111,200,000 | -147,600,000 | -237,400,000 | -22,600,000 | -385,400,000 | -1,400,000 | ||||||||||
maturities of investments | 119,300,000 | 142,300,000 | 122,000,000 | 34,200,000 | 354,100,000 | 500,000 | 12,800,000 | 3,800,000 | ||||||||||
sales of investments | -300,000 | 22,200,000 | 7,900,000 | 1,700,000 | 1,300,000 | 1,600,000 | 2,600,000 | 5,100,000 | ||||||||||
proceeds from issuances of common stock | 500,000 | 100,000 | ||||||||||||||||
proceeds from exercise of options | 200,000 | 1,200,000 | 1,600,000 | |||||||||||||||
change in fair value of preferred stock warrant liabilities | 0 | |||||||||||||||||
change in fair value of derivative liability on notes | 0 | |||||||||||||||||
amortization of debt discount | 0 | |||||||||||||||||
gain on extinguishment of debt | 0 | |||||||||||||||||
non-cash interest expense | ||||||||||||||||||
non-cash service expense | 0 | |||||||||||||||||
purchase of intangible assets | 0 | |||||||||||||||||
proceeds from the exercise of preferred stock warrants | 0 | |||||||||||||||||
proceeds from reverse recapitalization, net of redemptions, secondaries and costs | 1,000,000 | |||||||||||||||||
supplemental disclosures of non-cash financing and investing activities: | ||||||||||||||||||
payments for reverse recapitalization and transaction costs | ||||||||||||||||||
conversion of preferred stock for common stock | ||||||||||||||||||
acquisition of public and private placement warrants | ||||||||||||||||||
equity issued for acquisitions | ||||||||||||||||||
unpaid transaction costs | ||||||||||||||||||
convertible promissory notes issued for services | ||||||||||||||||||
cash paid for acquisitions, net of cash acquired | 0 | |||||||||||||||||
proceeds from series d preferred stock, net of issuance costs | ||||||||||||||||||
proceeds from series e preferred stock, net of issuance costs | ||||||||||||||||||
proceeds from promissory notes, net of issuance costs | ||||||||||||||||||
share–based compensation expense | ||||||||||||||||||
fiduciary liabilities |
